Kajian klinikal HIV di Houston, TX
17 kajian untuk HIV sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Mengambil pesertaKajian pemerhatian
- UT Health, Houston
- Thomas Street at Quentin Mease Health Center, Houston
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Mengambil pesertaFasa 3
- GSK Investigational Site, Houston
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Mengambil peserta
- Baylor College of Medicine, Houston
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Mengambil pesertaFasa 2/3
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire · 7 mi jauh
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Mengambil pesertaFasa 1/2
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- The Crofoot Research Center, Houston
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Mengambil peserta
- University of Texas M.D. Anderson Cancer Center, Houston
Positive Peers Intervention Clinical Trial
Mengambil peserta
- Thomas Street Clinic, Houston
Screen2Prevent (S2P)
Mengambil pesertaSukarelawan sihat dialu-alukan
- Baylor College of Medicine, Houston
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Mengambil pesertaFasa 2
- UT Health Houston, Houston
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Mengambil pesertaFasa 2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 7 mi jauh
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Mengambil peserta
- Houston Methodist Research Institute, Houston
Menopausal HT for Women Living With HIV (HoT)
Mengambil pesertaFasa 4
- Houston AIDS Research Team CRS (31473), Houston
Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
Mengambil peserta
- The University of Texas Health Science Center at Houston, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Mengambil pesertaFasa 2
- UT Health Houston, Houston
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Mengambil pesertaFasa 1/2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Kajian HIV di bandar lain
- Washington, DC22 kajian
- New York City, NY19 kajian
- Miami, FL17 kajian
- Baltimore, MD16 kajian
- San Francisco, CA15 kajian
- Atlanta, GA14 kajian
- Chicago, IL14 kajian
- Boston, MA11 kajian
- Philadelphia, PA11 kajian
- San Diego, CA10 kajian
- Los Angeles, CA9 kajian
- Seattle, WA8 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.